Cytomegalovirus (CMV) is the single most important infectious agent affecti
ng recipients of organ transplants. To evaluate the incidence and the clini
cal importance of CMV infection in renal transplants in Brazil, 37 patients
submitted to renal allograft transplants were tested periodically for the
presence of cytomegalovirus DNA in urine using the polymerase chain reactio
n (PCR), and for the presence of IgM and IgG antibodies against CMV by enzy
me-linked immunosorbent assay (ELISA) and indirect immunofluorescence (IFI)
. The PCR-amplified products were detected by gel electrophoresis and confi
rmed by dot-blot hybridization with oligonucleotide probes. Thirty-two of t
he 37 patients (86.4%) were positive by at least one of the three methods.
In six patients, PCR was the only test which detected the probable CMV infe
ction. Ten patients had a positive result by PCR before transplantation. In
general, the diagnosis was achieved earlier by PCR than by serologic tests
. Active infection occurred more frequently during the first four months af
ter transplantation. Sixteen of the 32 patients (50%) with active CMV infec
tion presented clinical symptoms consistent with CMV infection. Five patien
ts without evidence of active CMV infection by the three tests had only min
or clinical manifestations during follow-up. Our results indicate that PCR
is a highly sensitive procedure for the early detection of CMV infection an
d that CMV infection in renal transplant patients is a frequent problem in
Brazil.